NCT01839604 2017-03-06A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular CarcinomaAstraZenecaPhase 1 Completed58 enrolled 13 charts